The H1N1 influenza virus is still circulating in Indiana and the nation, but many Wayne County residents won’t be worried about a possible third wave of the illness this spring.
See the original post here:
H1N1 immunizations available through March from Wayne County Health Department (Palladium-Item)
Winter is winding down, spring is around the corner, and news about the H1N1 flu virus has just about disappeared from the news. So after all the stories about vaccine shortages and fears of a pandemic, what was the final tally in Missouri?
See original here:
H1N1 Update for Dallas County from Health Literacy Missouri (Buffalo Reflex)
BEIJING, March 12 (Bernama) — People with chronic diseases, the obese, and pregnant women face a renewed threat of contracting deadly infection of A/H1N1 influenza as spring draws near, reports Xinhua news agency on Friday.
Read more:
A/H1N1 Influenza Still A Long-term Threat (Bernama)
KUALA LUMPUR: More than 300 people were admitted to hospitals nationwide for suspected H1N1 influenza A over 11 days, since Feb 28.
Read this article:
Nation sees hike in influenza-like cases (The New Straits Times)
Immunizing children and adolescents with inactivated influenza vaccine resulted in reduced rates of influenza in their community compared to a similar community in which children did not receive the vaccine, suggesting that vaccinating children may help prevent transmission of the virus and offer protection for unimmunized community residents, according to a study in the March 10 issue of JAMA.
Go here to see the original:
Selective immunization of children may help reduce community transmission of influenza (News-Medical-Net)
The Centers for Disease Control and Prevention is evaluating the hard lessons learned during the H1N1 flu pandemic. While it may not be over, health experts are looking ahead to next season.
Read more here:
CDC Assesses The Hard Lessons Of H1N1 (WCCO Minneapolis – St. Paul)
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus.
Follow this link:
Successful Development of Broad Spectrum Human Monoclonal Antibodies Against Major Influenza Viruses (H1N1 and H5N1) (PR Newswire via Yahoo! Finance)
Novavax, Inc. (Nasdaq: NVAX) announced that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects. In this Stage B of Novavax’s pivotal study of …
A public health nurse prepares a dose of H1N1 vaccine at the Balboa Park Community Centre in Encino, California in this October 23, 2009 file photo.
Continue reading here:
H1N1 Seen Lying Low, Then Rising Again In Europe (Bernama)
Source: Reuters By Kate Kelland LONDON, March 8 (Reuters) – Europe is unlikely to see another wave of pandemic H1N1 flu soon but local epidemics are likely as winter returns to the Northern hemisphere, health …
More:
H1N1 seen lying low, then rising again in Europe (AlertNet)